Subscribe
Share
Share
Embed
PACUPod is your trusted source for evidence-based insights tailored to advanced clinical pharmacists and physicians. Each episode dives into the latest primary literature, covering medication-focused studies across critical care and many more. We break down study designs, highlight key findings, and objectively discuss clinical implications—without the hype—so you stay informed and ready to apply new evidence in practice. Whether you’re preparing for board certification or striving for excellence in patient care, PACUPod helps you make sense of the data, one study at a time.
Britany: Welcome back to PACULit. Today, we’re tackling an important question in cardiac arrest management: during out-of-hospital cardiac arrest resuscitation, should vasopressors or advanced airway placement come first? A recent secondary analysis of the Pragmatic Airway Resuscitation Trial, known as PART, sheds new light on this topic. Seth, what are your initial thoughts?
Seth: Thanks, Britany. Both vasopressors—primarily epinephrine—and airway management are critical components in cardiac arrest care. However, the optimal sequence for administering these interventions remains unclear. The original PART trial compared airway devices, but this secondary analysis specifically examined whether giving epinephrine before securing an airway, or vice versa, influences patient outcomes. Considering survival rates for out-of-hospital cardiac arrest remain below fifteen percent, any insight into optimizing protocols could have a significant impact.
Britany: Absolutely. Out-of-hospital cardiac arrest, or OHCA, affects approximately three hundred fifty thousand adults annually in the United States, with low survival to hospital discharge. Emergency medical services providers must carefully balance airway management and vasopressor administration during resuscitation. Previous trials, such as AIRWAYS-2 and PARAMEDIC2, evaluated airway device types and the efficacy of epinephrine, but neither addressed the sequence in which these interventions should be performed.
Seth: Exactly. This study analyzed data from two thousand four hundred four adult OHCA patients enrolled in PART. They were divided into two groups: one receiving vasopressors first, consisting of one thousand eight hundred twenty-one patients, and the other receiving airway management first, with five hundred eighty-three patients. The primary outcome was survival at seventy-two hours. Secondary outcomes included return of spontaneous circulation, or ROSC, survival to hospital discharge, neurological status, and cardiopulmonary resuscitation quality metrics.
Britany: It’s important to note that this analysis was observational within the randomized airway trial. Patients were not randomized based on the sequence of interventions. The researchers adjusted for confounding variables and clustering effects, excluding patients with missing timing or outcome data. This approach reflects real-world EMS practices and their impact on outcomes.
Seth: The key finding was that there was no significant difference in seventy-two-hour survival between the vasopressor-first and airway-first groups. The adjusted odds ratio was zero point nine six, with a confidence interval crossing one, indicating no statistical significance. Similarly, return of spontaneous circulation, hospital survival, and CPR quality metrics, such as compression fraction, were comparable between groups.
Britany: This suggests that EMS providers have flexibility in prioritizing vasopressors or airway management based on the clinical situation without compromising survival or CPR quality. Such flexibility can help streamline resuscitation efforts in the often chaotic prehospital environment.
Seth: However, there are limitations to consider. As a secondary analysis, the study was not randomized by intervention sequence, so unmeasured confounding factors may exist. The dataset lacked detailed information on EMS decision-making processes. Nonetheless, the large cohort size and statistical adjustments lend strength to the findings.
Britany: To put this in context, the original PART trial found no difference in seventy-two-hour survival between laryngeal tube and endotracheal intubation, supporting airway management flexibility. The AIRWAYS-2 trial similarly showed no superiority of supraglottic airway devices over intubation for functional outcomes. The PARAMEDIC2 trial demonstrated that epinephrine improves survival compared to placebo but does not improve neurological outcomes.
Seth: A Cochrane review further confirmed that vasopressors improve short-term survival in cardiac arrest. Interestingly, a large Japanese observational study using propensity score matching found that administering epinephrine before airway placement was associated with better one-month survival and neurological function, which contrasts with the PART findings. This discrepancy highlights ongoing uncertainty and the need for randomized trials specifically addressing intervention sequence.
Britany: The Japanese study by Okubo and colleagues suggested that early epinephrine administration before airway placement might enhance coronary and cerebral perfusion earlier in resuscitation. However, as an observational study, it is subject to bias and should be interpreted cautiously.
Seth: Another clinical consideration is the quality of airway management. First-pass success in intubation correlates with improved return of spontaneous circulation. Therefore, while the sequence may not significantly impact outcomes, proficiency and speed in airway placement remain critical.
Britany: Additionally, high-quality CPR is vital. Interruptions for airway placement or vasopressor administration can reduce chest compression fraction, which is linked to survival. This study found no difference in CPR quality metrics between groups, suggesting that either sequence can be integrated without compromising compressions.
Seth: From a pharmacologic standpoint, epinephrine dosing remains one milligram administered intravenously or intraosseously every three to five minutes during cardiac arrest. Providers should be mindful of potential drug interactions, but timely administration remains the priority.
Britany: It is also important to recognize that this study focused on adult patients with non-traumatic out-of-hospital cardiac arrest typical of urban and suburban EMS systems. Pediatric patients, traumatic arrests, and in-hospital cardiac arrests were excluded, so these findings do not apply to those populations. Comorbidities such as heart failure or pulmonary disease might influence resuscitation strategies but were not stratified in this analysis.
Seth: Those are important points. In cases of difficult airway or high aspiration risk, early airway management might be prioritized. Conversely, when vascular access is readily available, early vasopressor administration could be emphasized. This study supports tailoring interventions to the clinical context without fearing adverse survival impact.
Britany: Looking ahead, the authors call for randomized controlled trials specifically testing the sequence of vasopressor administration and airway management. Subgroup analyses could identify patient populations that benefit from one approach over the other. Advanced monitoring tools, such as end-tidal carbon dioxide and cerebral oximetry, might also guide timing and effectiveness of interventions.
Seth: Until such data are available, this evidence supports flexibility and clinical judgment. EMS protocols can allow either sequence, focusing on minimizing delays and maintaining high-quality CPR. Training and system factors that optimize airway and vasopressor delivery remain key.
Britany: To summarize, this secondary analysis of the PART trial found no significant difference in seventy-two-hour survival, return of spontaneous circulation, hospital survival, or neurological outcomes based on whether vasopressors or airway placement came first during out-of-hospital cardiac arrest. Cardiopulmonary resuscitation quality was unaffected. This supports a flexible, context-tailored approach to resuscitation.
Seth: Exactly. It reassures clinicians that either approach can be effective, allowing EMS providers to adapt based on patient factors, provider skill, and logistical considerations. The key is timely, high-quality interventions rather than rigid adherence to a specific sequence.
Britany: Thanks for the great discussion, Seth, and thank you to our listeners for joining us on PACULit. Stay tuned for more clinical updates aimed at optimizing patient care.
Seth: Thanks, Britany. Before we wrap up, I want to emphasize the importance of ongoing education and simulation training for EMS providers. Even though this study suggests flexibility in the sequence of vasopressor administration and airway management, the quality and speed of these interventions remain critical. Regular hands-on practice can improve first-pass airway success and timely epinephrine delivery, which ultimately impact patient outcomes.
Britany: Absolutely, Seth. Simulation scenarios that mimic the chaotic environment of out-of-hospital cardiac arrest help providers develop muscle memory and decision-making skills needed to adapt fluidly. They also allow teams to practice minimizing interruptions in chest compressions while managing airway and medications efficiently.
Seth: Another point to consider is the role of emerging technologies. Real-time feedback devices that monitor chest compression depth and rate can help maintain high-quality CPR during complex resuscitations. Integrating such tools with protocols that allow flexibility in intervention sequence could further optimize outcomes.
Britany: That’s a great addition. As prehospital care evolves, we may see increased use of mechanical CPR devices or even prehospital extracorporeal membrane oxygenation in select cases. These advances could change how we prioritize airway and vasopressor administration in the future.
Seth: Indeed. From a research perspective, future studies might explore patient-centered outcomes beyond survival, such as quality of life and neurological function at longer-term follow-up. Understanding how intervention sequence affects these outcomes could refine guidelines further.
Britany: Plus, incorporating biomarkers or imaging data might help identify which patients benefit most from early vasopressors versus airway management. Personalized resuscitation strategies could be the next frontier.
Seth: Until then, this PART secondary analysis provides valuable evidence supporting a pragmatic approach. EMS systems can focus on training, protocol flexibility, and minimizing delays rather than rigidly enforcing a specific sequence.
Britany: Well said, Seth. Thanks again for the insightful discussion. And to our listeners, remember that evidence-based practice is a dynamic process. Stay curious and keep learning.
Seth: Could not agree more. Thanks for having me, Britany. Looking forward to our next deep dive.
Britany: Me too. Take care, everyone, and keep striving for excellence in patient care.